UNICREDIT BANK/CALL/ABBVIE/140/0.1/15.01.25 Share Price

Warrant

DE000HC6UWH2

Real-time BOERSE MUENCHEN 14:40:35 27/06/2024 BST
3.2 EUR -1.84% Intraday chart for UNICREDIT BANK/CALL/ABBVIE/140/0.1/15.01.25
Current month+44.89%
1 month+55.24%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
27/06/24 3.2 -1.84%
26/06/24 3.26 +2.52%
25/06/24 3.18 -4.79%
24/06/24 3.34 +4.05%
21/06/24 3.21 -3.89%

Real-time BOERSE MUENCHEN

Last update June 27, 2024 at 02:40 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ABBVIE INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HC6UWH
ISINDE000HC6UWH2
Date issued 19/05/2023
Strike 140 $
Maturity 15/01/2025 (202 Days)
Parity 10 : 1
Emission price 2.01
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 4.27
Lowest since issue 1.24
Delta0.84x
Omega 4.230
Premium1.79x
Gearing5.06x
Moneyness 1.219
Difference Strike -29.44 $
Difference Strike %-21.03%
Spread 0.01
Spread %0.32%
Theoretical value 3.095
Implied Volatility 29.19 %
Total Loss Probability 21.10 %
Intrinsic value 2.808
Present value 0.2874
Break even 173.16 €
Theta-0.01x
Vega0.03x
Rho0.04x

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
171.2 USD
Average target price
183.2 USD
Spread / Average Target
+7.06%
Consensus